Tranilast: A New Application in the Cardiovascular Field as An Antiproliferative Drug
- 1 September 1998
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 16 (3) , 288-299
- https://doi.org/10.1111/j.1527-3466.1998.tb00359.x
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Factors Affecting Hypertrophic Scar Development in Median Sternotomy Incisions for Congenital Cardiac SurgeryJournal of the American College of Surgeons, 1997
- Inhibitory Effect of Tranilast on Activation and Transforming Growth Factor β1 Expression in Cultured Rat Stellate CellsBiochemical and Biophysical Research Communications, 1996
- Tranilast inhibits collagen synthesis in normal, scleroderma and keloid fibroblasts at a late passage culture but not at an early passage cultureJournal of Dermatological Science, 1995
- Inhibition by tranilast of collagen accumulation in hypersensitive granulomatous inflammation in vivo and of morphological changes anf functions of fibroblasts in vitroLife Sciences, 1994
- Effect of tranilast ophthalmic solution on allergic conjunctivitis in guinea pigs.Folia Pharmacologica Japonica, 1993
- Effect of tranilast, an anti-allergic drug, on the human keloid tissues.Folia Pharmacologica Japonica, 1992
- The effect of tranilast of the generation of reactive oxygen species.Journal of Pharmacobio-Dynamics, 1987
- The Inhibition Mechanism of Histamine Release by N-(3,4-Dimethoxycinnamoyl) Anthranilic AcidInternational Archives of Allergy and Immunology, 1985
- A Double Blind Controlled Trial of N‐(3′, 4′‐Dimethoxycinnamoyl) Anthranilic Acid on Children with Bronchial AsthmaAllergy, 1979
- Inhibition of hypersensitivity reactions by a new drug, N(3′,4′-dimethoxycinnamoyl) anthranilic acid (N-5′)Journal of Allergy and Clinical Immunology, 1976